Legislative Update

Drugs & Medication

Bills Committee Last action Date
HB 1424 - Cole - Prescription drugs; purpose of labeling. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/07/17
notes: Requires pharmacists to include on any label placed on the container in which any drug dispensed pursuant to a prescription is placed the purpose for which the drug has been prescribed and requires written prescriptions issued by prescribers to include the purpose for which the drug is prescribed.
HB 1447 - Miyares - Higher educational institutions; establishment of substance abuse recovery housing program. (H) Committee on Education(H) Left in Education02/07/17
notes: Requires, by July 1, 2021, certain baccalaureate public institutions of higher education to establish a substance abuse recovery housing program to provide recovering students with a substance-free dormitory environment and appropriate support services. The bill allows participating institutions to designate a portion of a dormitory, and states that no participating institution shall be required to designate an entire dormitory, for such program.
HB 1449 - Boysko - Naloxone; dispensing for use in opioid overdose reversal, etc. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/07/17
notes: Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides substance abuse treatment services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber, (ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose.
HB 1450 - Ware - Health insurer/health maintenance organization; response to notice from pharmacy's intermediary. (H) Committee on Commerce and Labor

(S) Committee on Commerce and Labor
(G) Acts of Assembly Chapter text (CHAP0615)03/16/17
notes: Requires a health insurer or health maintenance organization, or its intermediary (the carrier), when it receives notice from a pharmacy's intermediary of the pharmacy's agreement to accept reimbursement for its services at rates applicable to pharmacies that are preferred providers as payment in full, to respond to the notice in the same manner as it is currently required to respond to a notice received from the pharmacy. The measure does not require a carrier to contract with a pharmacy's intermediary and does not prohibit a carrier from contracting with a pharmacy's intermediary.
HB 1453 - LaRock - Naloxone; dispensing for use in opioid overdose reversal, etc. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0168)02/23/17
notes: Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides substance abuse treatment services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber, (ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose.
HB 1467 - Greason - Neonatal abstinence syndrome; Board of Health to adopt regulations to include as reportable disease. (H) Committee on Appropriations

(S) Committee on Finance
(G) Acts of Assembly Chapter text (CHAP0280)03/03/17
notes: Requires the Board of Health to adopt regulations to include neonatal abstinence syndrome on the list of diseases that shall be required to be reported.
HB 1610 - Garrett - Drug Control Act; Schedule I. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0414)03/13/17
notes: Adds certain chemical substances to Schedule I of the Drug Control Act. The Board of Pharmacy has added these substances to Schedule I in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. The bill also removes two substances, benzylfentanyl and thienylfentany, from Schedule I. The bill contains technical amendments.
HB 1616 - Lingamfelter - Felony homicide; certain drug offenses constitute second degree murder, penalty. (H) Committee on Appropriations

(S) Committee on Finance
(H) Failed to pass02/25/17
notes: Provides that a person is guilty of felony homicide, which constitutes second degree murder and is punishable by confinement of not less than five nor more than 40 years, if the underlying felonious act that resulted in the killing of another involved the manufacture, sale, gift, or distribution of a Schedule I or II controlled substance to another and (i) such other person's death results from his use of the controlled substance and (ii) the controlled substance is the proximate cause of his death. However, the bill also provides that if the person proves that he gave or distributed the controlled substance only as an accommodation, he is guilty instead of a Class 5 felony. The bill also provides that venue for a prosecution of this crime shall lie in the locality where the underlying felony occurred, where the use of the controlled substance occurred, or where death occurred. This bill serves to overrule the Court of Appeals of Virginia decision in Woodard v. Commonwealth, 61 Va. App. 567, 739 S.E.2d 220 (2013), aff'd, 287 Va. 276, 754 S.E.2d 309 (2014).
HB 1642 - Hope - Naloxone or other opioid antagonist; possession and administration. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0107)02/21/17
notes: Adds Department of Forensic Science employees and employees of the Office of the Chief Medical Examiner to the groups of individuals who may possess and administer naloxone or other opioid antagonist, provided that they have completed a training program. The bill contains an emergency clause.
HB 1661 - Greason - Administration of medications to treat adrenal crisis. (H) Committee on Education

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0713)03/24/17
notes: Provides that a prescriber may authorize an employee of (i) a school board, (ii) a school for students with disabilities, or (iii) an accredited private school who is trained in the administration of injected medications for the treatment of adrenal crisis resulting from a condition causing adrenal insufficiency to administer such medications to a student diagnosed with a condition causing adrenal insufficiency when the student is believed to be experiencing or about to experience an adrenal crisis pursuant to a written order or standing protocol issued within the course of the prescriber's professional practice and with the consent of the student's parents and provides that an employee of a school board, a school for students with disabilities, or an accredited private school who is trained in the administration of injected medications for the treatment of adrenal crisis resulting from a condition causing adrenal insufficiency who administers or assists in the administration of such medications to a student diagnosed with a condition causing adrenal insufficiency when the student is believed to be experiencing or about to experience an adrenal crisis in accordance with the prescriber's instructions shall not be liable for any civil damages for ordinary negligence in acts or omissions resulting from the rendering of such treatment.
HB 1746 - Rush - Higher educational institutions; possession and administration of epinephrine. (H) Committee for Courts of Justice

(S) Committee for Courts of Justice
(G) Acts of Assembly Chapter text (CHAP0294)03/03/17
notes: Authorizes and provides liability protection for employees of a public or private institution of higher education who are authorized by a prescriber and trained in the administration of epinephrine to possess and administer epinephrine.
HB 1750 - O'Bannon - Dispensing of naloxone; patient-specific order not required. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0174)02/23/17
notes: Provides that a pharmacist may dispense naloxone in the absence of a patient-specific prescription pursuant to a standing order issued by the Commissioner of Health authorizing the dispensing of naloxone or other opioid antagonist used for overdose reversal in the absence of an oral or written order for a specific patient issued by a prescriber and in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health.
HB 1775 - Hodges - Persons with developmental disabilities; terminology. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0458)03/13/17
notes: Corrects numerous sections of the Code of Virginia by replacing the term "intellectual disability" with "developmental disabilities" as appropriate.
HB 1845 - Cox - Model addiction recovery program; DCJS, et al., to develop. (H) Committee on Health, Welfare and Institutions

(S) Committee on Finance
(G) Acts of Assembly Chapter text (CHAP0758)03/24/17
notes: Requires the Department of Criminal Justice Services, in consultation with the Department of Behavioral Health and Developmental Services, to develop a model addiction recovery program that may be administered by sheriffs, deputy sheriffs, jail officers, administrators, or superintendents in any local or regional jail. The bill requires that participation in such program be voluntary and that such program address multiple aspects of the recovery process, including medical and clinical recovery, peer-to-peer support, availability of mental health resources, family dynamics, and aftercare aspects of the recovery process.
HB 1885 - Hugo - Opioids; limit on amount prescribed, extends sunset provision. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0249)02/24/17
notes: Provides that a prescriber who prescribes a controlled substance containing an opioid to a patient shall not prescribe an amount greater than a seven-day supply unless (i) in the professional medical judgment of the prescriber, more than a seven-day supply of the controlled substance containing an opioid is required to stabilize the patient's acute medical condition, or (ii) the prescription is for the management of pain associated with cancer, use in palliative or hospice care, or management of chronic pain not associated with cancer. The bill also requires a prescriber to obtain information from the Prescription Monitoring Program at the time of initiating a new course of treatment that includes the prescribing of opioids anticipated to last more than seven consecutive days. Currently, a prescriber must request such information when a course of opioid treatment is expected to last more than 14 consecutive days.
HB 1898 - Bell, John J. - Controlled substances; limits on prescription containing opioids. (H) Committee on Health, Welfare and Institutions(H) Left in Health, Welfare and Institutions02/07/17
HB 2125 - Minchew - Drug treatment courts; Counties of Clarke, Frederick, and Loudoun. (H) Committee for Courts of Justice(H) Left in Courts of Justice02/07/17
notes: Authorizes the establishment of drug treatment courts in the Counties of Clarke, Frederick, and Loudoun.
HB 2161 - Pillion - Opioids; workgroup to establish guidelines for prescribing. (H) Committee on Health, Welfare and Institutions

(S) Committee on Rules
(G) Acts of Assembly Chapter text (CHAP0180)02/23/17
notes: Requires the Secretary of Health and Human Resources to convene a workgroup that shall include representatives of the Departments of Behavioral Health and Developmental Services, Health, and Health Professions as well as representatives of the State Council of Higher Education for Virginia and each of the Commonwealth's medical schools, dental schools, schools of optometry, schools of pharmacy, physician assistant education programs, and nursing education programs to develop educational standards and curricula for training health care providers, including physicians, dentists, optometrists, pharmacists, physician assistants, and nurses, in the safe and appropriate use of opioids to treat pain while minimizing the risk of addiction and substance abuse. The workgroup shall report its progress and the outcomes of its activities to the Governor and the General Assembly by December 1, 2017.
HB 2162 - Pillion - Substance-exposed infants; study of barriers to treatment in Commonwealth. (H) Committee on Health, Welfare and Institutions

(S) Committee on Rules
(G) Acts of Assembly Chapter text (CHAP0197)02/23/17
notes: Directs the Secretary of Health and Human Resources (the Secretary) to convene a work group to study barriers to treatment of substance-exposed infants in the Commonwealth. Such work group shall include representatives of the Departments of Behavioral Health and Developmental Services and Health and Social Services and such other stakeholders as the Secretary may deem appropriate and shall (i) review current policies and practices governing the identification and treatment of substance exposed infants in the Commonwealth; (ii) identify barriers to treatment of substance exposed infants in the Commonwealth, including barriers related to identification and reporting of such infants, data collection, interagency coordination and collaboration, service planning, service availability, and funding; and (iii) develop legislative, budgetary, and policy recommendations for the elimination of barriers to treatment of substance-exposed infants in the Commonwealth. The Secretary shall report his findings to the Governor and the General Assembly by December 1, 2017.
HB 2163 - Pillion - Buprenorphine without naloxone; prescription limitation. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0794)04/05/17
notes: Provides that buprenorphine mono or products containing buprenorphine without naloxone shall be issued only for a patient who is pregnant.
HB 2164 - Pillion - Drugs of concern; drug of concern. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0181)02/23/17
notes: Adds any material, compound, mixture, or preparation containing any quantity of gabapentin, including any of its salts, to the list of drugs of concern.
HB 2165 - Pillion - Opiate prescriptions; electronic prescriptions. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0115)02/21/17
notes: Requires a prescription for any controlled substance containing an opiate to be issued as an electronic prescription and prohibits a pharmacist from dispensing a controlled substance that contains an opiate unless the prescription is issued as an electronic prescription, beginning July 1, 2020. The bill defines electronic prescription as a written prescription that is generated on an electronic application in accordance with federal regulations and is transmitted to a pharmacy as an electronic data file. The bill requires the Secretary of Health and Human Resources to convene a work group to review actions necessary for the implementation of the bill's provisions and report on the work group's progress to the Chairmen of the House Committee on Health, Welfare and Institutions and the Senate Committee on Education and Health by November 1, 2017 and a final report to such Chairmen by November 1, 2018.
HB 2166 - Pillion - Controlled substances; possession, penalty. (H) Committee for Courts of Justice

(S) Committee for Courts of Justice
(S) Passed by indefinitely in Courts of Justice (14-Y 0-N)02/08/17
notes: Lists possession of certain controlled substances (buprenorphine, cocaine, codeine, fentanyl, heroin, hydrocodone, hydromorphone, methadone, methamphetamine; methylphenidate, morphine, and oxycodone) as separate offenses under the existing crime of possession of controlled substances for the purpose of having the Virginia Criminal Sentencing Commission promulgate separate Virginia crime codes for such offenses. The bill does not alter the existing penalty for possession of these substances.
HB 2167 - Pillion - Opioids and buprenorphine; Boards of Dentistry and Medicine to adopt regulations for prescribing. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0291)03/03/17
notes: Directs the Boards of Dentistry and Medicine to adopt regulations for the prescribing of opioids and products containing buprenorphine. The bill contains an emergency clause.
HB 2301 - O'Bannon - Nurses, licensed practical; administration of vaccinations. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0182)02/23/17
notes: Removes the requirement that the supervision of licensed practical nurses administering vaccinations by registered nurses be immediate and direct.
HB 2317 - O'Bannon - Harm reduction programs; public health emergency, etc. (H) Committee on Appropriations

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0183)02/23/17
HJ 578 - Marshall, R.G. - Study; Jt Commission on Health Care; study of the long-term effects of marijuana use. (H) Committee on Rules(H) Tabled in Rules01/26/17
notes: Directs the Joint Commission on Health Care to study the long-term effects of marijuana use on individuals and populations. In conducting its one-year study, the Joint Commission shall review scientific studies, including studies of individuals in states that have legalized or decriminalized the use of marijuana for medical or recreational purposes, and other sources to determine the long-term effects of marijuana use on individuals.
HJ 597 - Marshall, R.G. - Study; Joint Commissionon Health Care; Study of heroin use in the Commonwealth; report. (H) Committee on Rules(H) Tabled in Rules01/26/17
notes: Directs the Joint Commission on Health Care to study heroin use in the Commonwealth, including the rates of use, the pathways that lead individuals to use, and initiatives focused on the prevention of heroin use and heroin overdose, including the use of naloxone to prevent heroin overdoses.
HJ 695 - Herring - Study; JLARC; sentencing of drug offenders; report. (H) Committee on Rules(H) Tabled in Rules01/26/17
notes: Directs the Joint Legislative Audit and Review Commission to study and report on the efficiency and effectiveness of the Virginia courts' sentencing of Schedule I and Schedule II drug offenders.
HJ 745 - Stolle - Substance-Exposed Infant Awareness Week; designating as first week of July 2017. (H) Committee on Rules

(S) Committee on Rules
(H) Bill text as passed House and Senate (HJ745ER)02/15/17
notes: Designates the first week of July, in 2017 and in each succeeding year, as Substance-Exposed Infant Awareness Week in Virginia.
SB 794 - Cosgrove - City of Chesapeake; pilot program for problem-solving docket. (S) Committee for Courts of Justice(S) Stricken at the request of Patron in Courts of Justice (12-Y 0-N)01/16/17
notes: Authorizes the City of Chesapeake to establish a pilot program to promote public safety and reduce recidivism by creating a problem-solving docket to address substance abuse, mental illness, issues unique to military service experienced by veterans, and issues related to previously incarcerated persons. The bill directs the Department of Behavioral Health and Developmental Services, the Department for Aging and Rehabilitative Services, and the Department of Veterans Services to provide assistance to the City of Chesapeake as requested. The bill provides for the City of Chesapeake to report on the pilot program to the Commissioners of the assisting agencies on or before November 30, 2018. The bill has an expiration date of July 1, 2019.
SB 831 - DeSteph - Marijuana; manufacture or possession, accommodation to another individual, penalty. (S) Committee for Courts of Justice(S) Stricken at the request of Patron in Courts of Justice (15-Y 0-N)01/23/17
notes: Provides that a person who proves that he manufactured marijuana or possessed marijuana with the intent to manufacture marijuana only as an accommodation to another individual who is not an inmate in a correctional facility, and without the intent to profit from such manufacture or possession with the intent to manufacture or to induce the recipient or intended recipient of the marijuana to use or become dependent upon marijuana, is guilty of a Class 1 misdemeanor. Currently, manufacturing marijuana or possessing marijuana with the intent to manufacture marijuana is a felony punishable by imprisonment of five to 30 years regardless of the person's intent.
SB 841 - Favola - Marijuana; possession or distribution for medical purposes, affirmative defense for treatment. (S) Committee for Courts of Justice(S) Stricken at the request of Patron in Courts of Justice (14-Y 0-N)01/30/17
notes: Provides an affirmative defense to prosecution for possession of marijuana if a person has a valid written certification issued by a practitioner for cannabidiol oil or THC-A oil for treatment of, or to alleviate the symptoms of, cancer, human immunodeficiency virus, acquired immune deficiency syndrome, Tourette syndrome, amyotrophic lateral sclerosis, multiple sclerosis, Crohn's disease, or complex regional pain syndrome. Under current law, only the treatment of intractable epilepsy is covered by the affirmative defense.
SB 848 - Wexton - Naloxone; dispensing for use in opioid overdose reversal, etc. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0055)02/20/17
notes: Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides substance abuse treatment services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber,(ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose.
SB 888 - Chafin - Civil immunity; emergency services and communications. (S) Committee for Courts of Justice(S) Stricken at the request of Patron in Courts of Justice (14-Y 0-N)01/30/17
notes: Extends immunity from civil liability to persons involved in providing, operating, or maintaining services or equipment used for emergency assistance, unless the act or omission that gave rise to the injury is a result of such person's gross negligence or willful misconduct. Under current law, such immunity is limited to persons who are communications services providers, a term defined in Title 58.1.
SB 944 - Chafin - Institutions of higher education; possession and administration of epinephrine. (H) Committee for Courts of Justice

(S) Committee for Courts of Justice
(G) Acts of Assembly Chapter text (CHAP0304)03/03/17
notes: Authorizes and provides liability protection for employees of a public or private institution of higher education who are authorized by a prescriber and trained in the administration of epinephrine to possess and administer epinephrine.
SB 1027 - Marsden - Cannabidiol oil and THC-A oil; permitting of pharmaceutical processors to manufacture and provide. (H) Committee for Courts of Justice

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0613)03/16/17
notes: Authorizes a pharmaceutical processor, after obtaining a permit from the Board of Pharmacy (the Board) and under the supervision of a licensed pharmacist, to manufacture and provide cannabidiol oil and THC-A oil to be used for the treatment of intractable epilepsy. The bill sets limits on the number of permits that the Board may issue and requires that the Board adopt regulations establishing health, safety, and security requirements for permitted processors. The bill provides that only a licensed practitioner of medicine or osteopathy who is a neurologist or who specializes in the treatment of epilepsy may issue a written certification to a patient for the use of cannabidiol oil or THC-A oil. The bill also requires that a practitioner who issues a written certification for cannabidiol oil or THC-A oil, the patient issued such certification, and, if the patient is a minor or incapacitated, the patient's parent or legal guardian register with the Board. The bill requires further that a pharmaceutical processor shall not provide cannabidiol oil or THC-A oil to a patient or a patient's parent or legal guardian without first verifying that the patient, the patient's parent or legal guardian if the patient is a minor or incapacitated, and the practitioner who issued the written certification have registered with the Board. Finally, the bill provides an affirmative defense for agents and employees of pharmaceutical processors in a prosecution for the manufacture, possession, or distribution of marijuana. This bill contains an emergency clause.
SB 1031 - Marsden - Naloxone or other opioid antagonist; possession and administration. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0003)02/13/17
notes: Adds Department of Forensic Science employees and employees of the Office of the Chief Medical Examiner to the groups of individuals who may possess and administer naloxone or other opioid antagonist, provided that they have completed a training program. The bill contains an emergency clause.
SB 1116 - McPike - Public school employees, certain; assistance with student insulin pumps by register nurse, etc. (H) Committee on Education

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0811)04/05/17
notes: Authorizes public school employees who are trained in the administration of insulin and glucagon to assist students who are diagnosed with diabetes and carry insulin pumps with the insertion or reinsertion of the insulin pump or any of its parts. The bill also provides liability protection for such employees.
SB 1166 - Reeves - Insurance; preauthorization for abuse-deterrent opioids. (S) Committee on Commerce and Labor(S) Passed by indefinitely in Commerce and Labor with letter (14-Y 1-N)01/30/17
notes: Requires any health carrier offering a health benefit plan that covers prescription drugs and applies a formulary to such coverage to offer in its formulary at least two classes of abuse-deterrent opioids as a tier 1 option that does not require the prescribing provider to utilize a preauthorization process.
SB 1180 - Chafin - Opioids and buprenorphine; Boards of Dentistry and Medicine to adopt regulations for prescribing. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0682)03/20/17
notes: Directs the Boards of Dentistry and Medicine to adopt regulations for the prescribing of opioids and products containing buprenorphine. The bill contains an emergency clause.
SB 1215 - Stuart - Public schools; possession of glucagon. (S) Committee on Education and Health(S) Passed by indefinitely in Education and Health (15-Y 0-N)01/26/17
notes: Requires local school boards to adopt and implement policies for the possession and administration of glucagon in every school that one or more students with diabetes attend and requires the Board of Education to adopt and implement policies for the possession and administration of glucagon in every school for students with disabilities that one or more students with diabetes attend. The bill allows a school nurse, an employee of the school board, an employee of a local governing body, an employee of a local health department, or an employee of the school for students with disabilities who is authorized by a prescriber and trained in the administration of glucagon to any student diagnosed with diabetes believed to be suffering from or about to suffer from life-threatening hypoglycemia.
SB 1232 - Dunnavant - Opioids; limit on amount prescribed, extends sunset provision. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0252)02/24/17
notes: Prohibits a prescriber providing treatment for a patient in an emergency department of a corporation, facility, or institution licensed, owned, or operated by the Commonwealth to provide health care from prescribing a controlled substance containing an opioid in a quantity greater than a three-day supply, as determined in accordance with the prescriber's directions for use. The bill also prohibits a pharmacist from dispensing a controlled substance containing an opioid pursuant to a prescription issued by a prescriber providing treatment to a patient in the emergency department of a corporation, facility, or institution licensed, owned, or operated by the Commonwealth to provide health care unless the prescription complies with the requirements of the bill. The bill has an expiration date of July 1, 2020.
SB 1244 - Dunnavant - Glucagon; administration by emergency medical services providers. (S) Committee on Education and Health(S) Passed by indefinitely in Education and Health with letter (15-Y 0-N)01/26/17
SB 1298 - Vogel - Marijuana; possession or distribution for medical purposes, affirmative defense for treatment. (H) Committee for Courts of Justice

(S) Committee for Courts of Justice
(H) Left in Courts of Justice02/21/17
notes: Provides an affirmative defense to prosecution for possession of marijuana if a person has a valid written certification issued by a practitioner for cannabidiol oil or THC-A oil for treatment of, or to alleviate the symptoms of, cancer, glaucoma, human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, Crohn's disease, Alzheimer's disease, nail patella, cachexia or wasting syndrome, multiple sclerosis, or complex regional pain syndrome. Under current law, only the treatment of intractable epilepsy is covered by the affirmative defense.
SB 1403 - Dunnavant - Controlled substances; use of FDA-approved substance upon publication of final rule, etc. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0432)03/13/17
notes: Directs the Board of Pharmacy to initiate action to deschedule or reschedule cannabidiol or any product containing cannabidiol that has been approved as a prescription medication by the U.S. Food and Drug Administration pursuant to 21 U.S.C. 360bb and 21 U.S.C. 355 within 90 days of publication in the Federal Register of an interim final rule.
SB 1452 - Lucas - Marijuana; possession or distribution for medical purposes. (H) Committee for Courts of Justice

(S) Committee on Education and Health
(H) Left in Courts of Justice02/21/17
notes: Provides an affirmative defense to prosecution for possession of marijuana if a person has a valid written certification issued by a practitioner for cannabidiol oil or THC-A oil for treatment of, or to alleviate the symptoms of, cancer. Under current law, only the treatment of intractable epilepsy is covered by the affirmative defense.
SB 1546 - Vogel - Drug Control Act; adds certain chemical substances to Schedule I. (H) Committee on Health, Welfare and Institutions

(S) Committee on Education and Health
(G) Acts of Assembly Chapter text (CHAP0434)03/13/17
notes: Adds certain chemical substances to Schedule I of the Drug Control Act. The Board of Pharmacy has added these substances to Schedule I in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. The bill also removes two substances, benzylfentanyl and thienylfentanyl, from Schedule I. The bill contains technical amendments.
SJ 282 - Dunnavant - Substance-Exposed Infant Awareness Week. (H) Committee on Rules

(S) Committee on Rules
(S) Bill text as passed Senate and House (SJ282ER)02/21/17
notes: Designates the first week of July, in 2017 and in each succeeding year, as Substance-Exposed Infant Awareness Week in Virginia.
« Return to Legislative Categories